Next Article in Journal
A Stepwise Approach Using Metastatic Lymph Node Ratio-Combined Thyroglobulin for Customization of [18F]FDG-PET/CT Indication to Detect Persistent Disease in Patients with Papillary Thyroid Cancer
Previous Article in Journal
Fatigue in Kidney Transplantation: A Systematic Review and Meta-Analysis
Article

Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists

1
Expert Center for Rare Genetic Cardiovascular Diseases, Department of Cardiology, “Prof. Dr. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania
2
“Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania
3
Department of Nuclear Medicine and Ultrasonography, Fundeni Clinical Institute, 022328 Bucharest, Romania
*
Author to whom correspondence should be addressed.
Current Address: “Prof. Dr. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases, 022328 Bucharest, Romania; 3rd Cardiology Department, 258 Fundeni Street, 022328 Bucharest, Romania.
Academic Editor: Stefano Perlini
Diagnostics 2021, 11(5), 834; https://doi.org/10.3390/diagnostics11050834
Received: 24 March 2021 / Revised: 26 April 2021 / Accepted: 4 May 2021 / Published: 6 May 2021
(This article belongs to the Section Pathology and Molecular Diagnostics)
Cardiac amyloidosis (CA) is a restrictive cardiomyopathy characterized by deposition of amyloid in the myocardium and recent studies revealed it is more frequently seen than we thought. Advances in diagnosis and treatment have been made over the last few years that make it desirable to diagnose CA without delay, and that may require extra education. An online survey was conducted among cardiologists from Romania, representing the first assessment of the knowledge of CA among them, with 195 cardiologists answering the questionnaire. There was a wide variation in their knowledge regarding CA. Our participants had limited experience with CA and reported a significant delay between first cardiac symptoms and diagnosis. We address the gaps in knowledge that were identified as educational opportunities in the main identified areas: prevalence and treatment of wild type transthyretin amyloidosis (ATTRwt), prevalence of variant transthyretin amyloidosis (ATTRv) in Romania, diagnosis of CA, the delay in CA diagnosis and available treatment options. Awareness among cardiologists is the most important challenge in diagnosing CA. Romanian cardiologists are partially aware of this topic, but there are still gaps in their knowledge. Educational programs can improve screening of patients with a high suspicion for this progressive condition the prognosis of which has been dramatically changed by the new treatment options. View Full-Text
Keywords: amyloidosis; cardiologist; awareness; survey; ATTR amyloidosis; cardiologist; awareness; survey; ATTR
Show Figures

Figure 1

MDPI and ACS Style

Adam, R.; Neculae, G.; Stan, C.; Jurcut, R. Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists. Diagnostics 2021, 11, 834. https://doi.org/10.3390/diagnostics11050834

AMA Style

Adam R, Neculae G, Stan C, Jurcut R. Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists. Diagnostics. 2021; 11(5):834. https://doi.org/10.3390/diagnostics11050834

Chicago/Turabian Style

Adam, Robert, Gabriela Neculae, Claudiu Stan, and Ruxandra Jurcut. 2021. "Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists" Diagnostics 11, no. 5: 834. https://doi.org/10.3390/diagnostics11050834

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop